Bio-Rad Laboratories, Inc. (BIO) is scheduled to announce Q3 earnings results on Wednesday, October 29th, after market close. The consensus EPS Estimate is $1.9 ...

The outlook for full year 2025 remains unchanged at flat to 1% currency-neutral revenue growth, consistent with the Q2 update. Margins guidance is also unchanged. Q3 reported a slight revenue and ...

Upslope Capital Management, an investment management company, released its third-quarter investor letter. A copy of the ...

Biodesix, Inc., a leading diagnostics solutions company, today announced the signing of an expanded partnership agreement ...

Bio-Rad Laboratories Inc. reported its earnings for the second quarter of 2025, revealing a modest increase in net sales and a stable financial performance. Despite a challenging market environment, ...

Investing.com - Bio-Rad Labs B (NYSE: BIOb) reported third quarter EPS of $2.26, $0.37 better than the analyst estimate of $1.89.

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the ...

Detroit, Michigan--(Newsfile Corp. - October 13, 2025) - Artificial Intelligence Technology Solutions, Inc. (OTCID: AITX) (the "Company"), a global leader in AI-driven security and productivity ...

PHILADELPHIA, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell ...

Andhra Pradesh Chief Minister N. Chandrababu Naidu inaugurated the socio-economic initiatives of the Chinta Sasidhar Foundation, the philanthropic arm of the Vishwa Samudra Group, on the Nandha ...

The firm is projecting a gradual recovery of the academic market in the face of ongoing funding uncertainties and a government shutdown.